Lillian Smith

Insider Reports History

Entity
Individual
Location
210 East Grand Ave, South San Francisco, California
Signature
/s/Lillian Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lillian Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. VP, Corporate Counsel Common Stock 140 K $446 K $3.17 Apr 1, 2023 Direct

Insider Reports Filed by Lillian Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 5, 2023 VP, Corporate Counsel
ALLO Allogene Therapeutics, Inc. Apr 1, 2023 0 $0 3 Apr 5, 2023 VP, Corporate Counsel